학술논문
Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants
Document Type
Article
Author
Source
In: Clinical and Translational Science . (Clinical and Translational Science, July 2023, 16(7):1210-1219)
Subject
Language
English
ISSN
17528062
17528054
17528054